← Open Payments lookup

ERIN ZIMMERMAN: Open Payments

NPI 1871091058 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,300 in 82 payments from 18 companies in 2025. Trend: 2023 $1,331 · 2024 $993 · 2025 $1,300

Food & beverage: $1,300
CompanyPaymentsAmount
Janssen Biotech, Inc.26$343
ABBVIE INC.8$156
Takeda Pharmaceuticals U.S.A., Inc.11$137
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$114
Boston Scientific Corporation1$67
GENZYME CORPORATION3$60
Regeneron Healthcare Solutions, Inc.2$52
Ipsen Biopharmaceuticals, Inc2$49
Phathom Pharmaceuticals, Inc.8$49
Gilead Sciences, Inc.2$45

Products named: TREMFYA, ENTYVIO, XIFAXAN, DUPIXENT, OverStitch Endoscopic Suturing System, RINVOQ, IQIRVO, VOQUEZNA.

Industry payments across NE — which companies pay providers there.